Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/IN8BIO-INC-114862294/nieuws/In8bio-Inc-Doseert-eerste-patient-in-Fase-2-klinische-studie-van-Inb-400-in-nieuw-gediagnosticeer-46580010/?utm_source=whatsapp&utm_medium=social&utm_campaign=share